Jeffrey Gersch

627 total citations
14 papers, 401 citations indexed

About

Jeffrey Gersch is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jeffrey Gersch has authored 14 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Jeffrey Gersch's work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Jeffrey Gersch is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Jeffrey Gersch collaborates with scholars based in United States, Cameroon and Spain. Jeffrey Gersch's co-authors include Gavin Cloherty, Mary C. Kuhns, Bo Wang, Ivana Carey, Geoffrey Dusheiko, Kosh Agarwal, Ka‐Cheung Luk, Anne L. McNamara, Vera Holzmayer and Emily K. Butler and has published in prestigious journals such as Hepatology, Gut and Scientific Reports.

In The Last Decade

Jeffrey Gersch

14 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Gersch United States 7 383 355 30 30 12 14 401
Giovanna Moscato Italy 6 363 0.9× 311 0.9× 46 1.5× 25 0.8× 3 0.3× 8 402
Robério Amorim de Almeida Pondé Brazil 12 275 0.7× 259 0.7× 67 2.2× 33 1.1× 7 0.6× 21 343
Jörg M. Pollok Germany 5 426 1.1× 370 1.0× 48 1.6× 51 1.7× 48 4.0× 6 477
Vincent Ngai Hong Kong 6 474 1.2× 444 1.3× 45 1.5× 29 1.0× 16 1.3× 6 500
Ossama Ashraf Ahmed Egypt 7 162 0.4× 180 0.5× 23 0.8× 9 0.3× 14 1.2× 27 226
Dulce Alfaiate France 8 315 0.8× 286 0.8× 50 1.7× 43 1.4× 3 0.3× 15 370
C. Mayerat Switzerland 7 314 0.8× 317 0.9× 36 1.2× 14 0.5× 3 0.3× 9 354
Frauke Metzler Germany 6 474 1.2× 461 1.3× 31 1.0× 17 0.6× 45 3.8× 6 510
Lorenzo Piermatteo Italy 9 137 0.4× 125 0.4× 75 2.5× 29 1.0× 8 0.7× 26 225
Chi–Jen Chu United States 6 1.1k 2.7× 1.0k 2.9× 71 2.4× 22 0.7× 13 1.1× 7 1.1k

Countries citing papers authored by Jeffrey Gersch

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Gersch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Gersch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Gersch more than expected).

Fields of papers citing papers by Jeffrey Gersch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Gersch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Gersch. The network helps show where Jeffrey Gersch may publish in the future.

Co-authorship network of co-authors of Jeffrey Gersch

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Gersch. A scholar is included among the top collaborators of Jeffrey Gersch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Gersch. Jeffrey Gersch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rodgers, Mary A., Pir Ahmad Shah, Mark Anderson, et al.. (2023). Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection. Hepatology Communications. 7(4). 6 indexed citations
2.
Luk, Ka‐Cheung, Jeffrey Gersch, Barbara J. Harris, et al.. (2021). More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication. Scientific Reports. 11(1). 23838–23838. 6 indexed citations
3.
Mak, Lung‐Yi, Gavin Cloherty, Danny Ka‐Ho Wong, et al.. (2020). HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 73(6). 2167–2179. 56 indexed citations
4.
Seto, Wai‐Kay, Lung‐Yi Mak, Gavin Cloherty, et al.. (2020). Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Gut. 70(4). 775–783. 57 indexed citations
5.
Coller, Kelly E., Jeffrey Gersch, Matthew Frankel, et al.. (2020). Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection. Emerging infectious diseases. 26(2). 265–272. 8 indexed citations
6.
7.
Carey, Ivana, Jeffrey Gersch, Matthew Bruce, et al.. (2019). FRI-159-Can HBcrAg and pre-genomic HBV RNA predict the risk of ALT flares after nucleoside analogue therapy withdrawal: delineating the clinical utility of new biomarkers?. Journal of Hepatology. 70(1). e458–e458. 2 indexed citations
8.
9.
Shah, Pir Ahmad, et al.. (2019). THU-222-The application of novel HBV pgRNA assay to predict HBeAg clearance on long-term nucleos (t)ide analogues. Journal of Hepatology. 70(1). e262–e263. 1 indexed citations
10.
11.
Butler, Emily K., Jeffrey Gersch, Anne L. McNamara, et al.. (2018). Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog‐Treated or Untreated Patients During Chronic and Acute Infection. Hepatology. 68(6). 2106–2117. 117 indexed citations
12.
Coller, Kelly E., Emily K. Butler, Ka‐Cheung Luk, et al.. (2018). Development and performance of prototype serologic and molecular tests for hepatitis delta infection. Scientific Reports. 8(1). 16 indexed citations
13.
Butler, Emily K., Jeffrey Gersch, Anne L. McNamara, et al.. (2018). HBV serum DNA and RNA levels in nucleos(t)ide analogue-treated or untreated patients during chronic and acute infection. 2 indexed citations
14.
Frankel, Matthew, Kinnari Pandya, Jeffrey Gersch, Sarah Siddiqui, & George J. Schneider. (2017). Development of the Abbott RealTime ZIKA assay for the qualitative detection of Zika virus RNA from serum, plasma, urine, and whole blood specimens using the m2000 system. Journal of Virological Methods. 246. 117–124. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Moscato Breakdown of academic impact, for papers by Robério Amorim de Almeida Pondé Breakdown of academic impact, for papers by Jörg M. Pollok Breakdown of academic impact, for papers by Vincent Ngai Breakdown of academic impact, for papers by Ossama Ashraf Ahmed Breakdown of academic impact, for papers by Dulce Alfaiate Breakdown of academic impact, for papers by C. Mayerat Breakdown of academic impact, for papers by Frauke Metzler Breakdown of academic impact, for papers by Lorenzo Piermatteo Breakdown of academic impact, for papers by Chi–Jen Chu
Rankless by CCL
2026